Clinical Trial Update: Pivotal Study to Evaluate Efficacy and Safety of SP5M002 Inj. as Compared to Synovian Inj. in Patients With Mild to Moderate Knee Osteoarthritis [Phase 3]

View source ↗

Summary

A Phase 3 pivotal trial evaluating SP5M002 injectable versus Synovian injectable in mild-to-moderate knee osteoarthritis is ongoing; the study status is ACTIVE_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Osteoarthritis
• Osteoarthritis

Drugs mentioned

• SP5M002 Inj.
• Synovian Inj.

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Osteoarthritis | Phase 3 | Status: ACTIVE_NOT_RECRUITING